Expression of L amino acid transport system 1 and analysis of iodine-123-methyltyrosine tumor uptake in a pancreatic xenotransplantation model using fused high-resolution-micro-SPECT-MRI

Hepatobiliary and Pancreatic Diseases International

Volumn 10, Issue 1, 2011, Pages 30-37

  Von Forstner, Corinna ^a   Zuhayra, Maaz ^a   Ammerpohl, Ole ^a   Zhao, Yi ^a   Tiwari, Sanjay ^a   Jansen, Olav ^a   Kalthoff, Holger ^a   Henze, Eberhard ^a   Egberts, Jan Hendrik ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

High resolution micro SPECT; Iodine 123 methyltyrosine; L amino acid transport system 1; Pancreatic ductal adenocarcinoma; Xenotransplantation model

Indexed keywords

AMINO ACID TRANSPORTER; IODINE 123; METIROSINE; METIROSINE IODINE 123; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN COLO357; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; GENE EXPRESSION; HIGH RESOLUTION MICRO SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PANCREAS CARCINOMA; PANCREAS TUMOR; PANCREATITIS; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKIN TRANSPLANTATION; XENOTRANSPLANTATION;

EID: 79952066589     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(11)60004-0     Document Type: Article

References (35)

1. 123I]iodoalpha-methyl tyrosine and SPECT. J Nucl Med 1989;30:110-112.
2. Vaalburg W, Coenen HH, Crouzel C, Elsinga PH, Långström B, Lemaire C, et al. Amino acids for the measurement of protein synthesis in vivo by PET. Int J Rad Appl Instrum B 1992;19: 227-237.
3. Kubota K, Ishiwata K, Kubota R, Yamada S, Takahashi J, Abe Y, et al. Feasibility of fluorine-18-fluorophenylalanine for tumor imaging compared with carbon-11-L-methionine. J Nucl Med 1996;37:320-325. (Pubitemid 26151526)
4. Willemsen AT, van Waarde A, Paans AM, Pruim J, Luurtsema G, Go KG, et al. In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET. J Nucl Med 1995;36:411-419.
5. Isselbacher KJ. Sugar and amino acid transport by cells in culture - differences between normal and malignant cells. N Engl J Med 1972;286:929-933.
6. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33: 1972-1980.
7. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409-1415. (Pubitemid 26340597)
8. Arnér ES, Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacol Ther 1995;67:155-186.
9. Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 1998;4:1334-1336.
10. Barthel H, Cleij MC, Collingridge DR, Hutchinson OC, Osman S, He Q, et al. 3′-deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to anti-proliferative therapy in vivo with positron emission tomography. Cancer Res 2003;63:3791-3798. (Pubitemid 36793068)
11. Kubota K, Matsuzawa T, Fujiwara T, Sato T, Tada M, Ido T, et al. Differential diagnosis of AH109A tumor and inflammation by radioscintigraphy with L-[methyl-11C]methionine. Jpn J Cancer Res 1989;80:778-782. (Pubitemid 20023052)
12. Kubota R, Kubota K, Yamada S, Tada M, Takahashi T, Iwata R, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995;36:484-492.
13. 18F-FEC in PET/ MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer. J Nucl Med 2008;49:1362-1370.
14. Martin WH, Delbeke D, Patton JA, Sandler MP. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose. Radiology 1996;198:225-231.
15. Jager PL, Franssen EJ, Kool W, Szabó BG, Hoekstra HJ, Groen HJ, et al. Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl- tyrosine in extracranial tumors. J Nucl Med 1998;39:1736-1743. (Pubitemid 28473522)
16. Yanagida M, Hayano T, Yamauchi Y, Shinkawa T, Natsume T, Isobe T, et al. Human fibrillarin forms a sub-complex with splicing factor 2-associated p32, protein arginine methyltransferases, and tubulins alpha 3 and beta 1 that is independent of its association with preribosomal ribonucleoprotein complexes. J Biol Chem 2004;279:1607-1614. (Pubitemid 38084425)
17. Lahoutte T, Mertens J, Caveliers V, Franken PR, Everaert H, Bossuyt A. Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain. J Nucl Med 2003;44:1489-1494. (Pubitemid 39663365)
18. Samnick S, Bader JB, Hellwig D, Moringlane JR, Alexander C, Romeike BF, et al. Clinical value of iodine-123-alphamethyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up. J Clin Oncol 2002;20:396-404. (Pubitemid 34072521)
19. Keyaerts M, Lahoutte T, Neyns B, Caveliers V, Vanhove C, Everaert H, et al. 123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients. Eur J Nucl Med Mol Imaging 2007;34:994-1002. (Pubitemid 46919545)
20. Sipos B, Moser S, Kalthoff H, Torok V, Löhr M, Klöppel G. A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch 2003;442:444-452. (Pubitemid 36718311)
21. Egberts JH, Schniewind B, Sipos B, Hinz S, Kalthoff H, Tepel J. Superiority of extended neoadjuvant chemotherapy with gemcitabine in pancreatic cancer: a comparative analysis in a clinically adapted orthotopic xenotransplantation model in SCID beige mice. Cancer Biol Ther 2007;6:1227-1232. (Pubitemid 351590376)
22. Tisljar U, Kloster G, Ritzl F, Stocklin G. Accumulation of radioiodinated L-alpha-methyltyrosine in pancreas of mice: concise communication. J Nucl Med 1979;20:973-976. (Pubitemid 10209261)
23. Grützmann R, Pilarsky C, Ammerpohl O, Lüttges J, Böhme A, Sipos B, et al. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 2004;6:611-622. (Pubitemid 39411099)
24. Pilarsky C, Ammerpohl O, Sipos B, Dahl E, Hartmann A, Wellmann A, et al. Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling. J Cell Mol Med 2008;12:2823-2235.
25. Müerköster SS, Werbing V, Koch D, Sipos B, Ammerpohl O, Kalthoff H, et al. Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma - epigenetic down-regulation of caspases. Int J Cancer 2008;123:1751-1760.
26. Carnochan P, Deehan B, Trivedi M, Tombs A, Sandle J, Ott R. Uptake of radiolabelled tyrosine and iodo-methyl tyrosine in experimental rat tumours: influence of blood flow and tumour growth rate. J Nucl Biol Med 1994;38:92-95.
27. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009;324:1457-1461.
28. Tepel J, Kruse ML, Kapischke M, Haye S, Sipos B, Kremer B, et al. Adjuvant treatment of pancreatic carcinoma in a clinically adapted mouse resection model. Pancreatology 2006;6:240-247. (Pubitemid 44114494)
29. Egberts JH, Cloosters V, Noack A, Schniewind B, Thon L, Klose S, et al. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 2008; 68:1443-1450. (Pubitemid 351346852)
30. Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, et al. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med 1999;40:1784-1791. (Pubitemid 29523570)
31. 18F-FDG PET: clinical value in pancreatic lesions--a prospective study with 104 patients. J Nucl Med 2004;45:1279-1286.
32. Sendler A, Avril N, Helmberger H, Stollfuss J, Weber W, Bengel F, et al. Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitations. World J Surg 2000;24:1121-1129.
33. Pakzad F, Groves AM, Ell PJ. The role of positron emission tomography in the management of pancreatic cancer. Semin Nucl Med 2006;36:248-256. (Pubitemid 43817848)
34. 18F]fluoroethyl)- L-tyrosine for tumor imaging. J Nucl Med 1999;40:205-212.
35. Ruf J, Lopez Hänninen E, Böhmig M, Koch I, Denecke T, Plotkin M, et al. Impact of FDG-PET/MRI image fusion on the detection of pancreatic cancer. Pancreatology 2006;6:512-519. (Pubitemid 46360707)